Toll-like receptor 9 interaction with CpG ODN - An in silico analysis approach

Theoretical Biology and Medical Modelling

Volumn 10, Issue 1, 2013, Pages

  Zhou, Wei ^a   Li, Yan ^b   Pan, Xichun ^c   Gao, Yuan ^a   Li, Beiping ^a   Qiu, Zhengliang ^b   Liang, Long ^a   Zhou, Hong ^c   Yue, Junjie ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 9; AMINO ACID; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; DNA; LEUCINE RICH REPEAT PROTEINS; LEUCINE-RICH REPEAT PROTEINS; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HOMOZYGOTE; HUMAN; MALE; PROMOTER REGION; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; HYDROGEN BOND; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TOLL-LIKE RECEPTOR 9; AMINO ACIDS; COMPUTER SIMULATION; DNA; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS;

EID: 84874934775     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-10-18     Document Type: Article

References (39)

1. Toll-Like receptors (TLRs) and their ligands. Uematsu S, Akira S, Handb Exp Pharmacol 2008 183 1 20 10.1007/978-3-540-72167-3-1 18071652
2. A: Leucine-rich repeats and pathogen recognition in Toll-like receptors. Bell JK, Mullen GE, Leifer CA, Trends Immunol 2003 24 528 533 10.1016/S1471-4906(03)00242-4 14552836 (Pubitemid 37205203)
3. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L, Nature 2000 408 111 115 10.1038/35040600 11081518
4. Toll-Like receptors and their ligands. Barton GM, Medzhitov R, Curr Top Microbiol Immunol 2002 270 81 92 10.1007/978-3-642-59430-4-5 12467245 (Pubitemid 35448154)
5. Structures of TLR-ligand complexes. Jin MS, Lee JO, Curr Opin Immunol 2008 20 414 419 10.1016/j.coi.2008.06.002 18585456
6. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Bell JK, Mullen GE, Leifer CA, Mazzoni A, Davies DR, Segal DM, Trends Immunol 2003 24 528 533 10.1016/S1471-4906(03)00242-4 14552836 (Pubitemid 37205203)
7. Identification and characterisation of the DNA binding domain of CpG-binding protein. Lee JH, Voo KS, Skalnik DG, J Biol Chem 2001 276 44669 44676 10.1074/jbc.M107179200 11572867
8. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, Chapman HA, Barton GM, Nature 2008 456 658 662 10.1038/nature07405 18820679
9. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL, Nat Immunol 2008 9 1407 1414 10.1038/ni.1669 18931679
10. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. Peter ME, Kubarenko AV, Weber AN, Dalpke AH, J Immunol 2009 182 7690 7697 10.4049/jimmunol.0900819 19494293
11. A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness. Kubarenko AV, Ranjan S, Rautanen A, Mills TC, Wong S, Vannberg F, Neumaier M, Bekeredjian-Ding I, Hill AV, Ahmad-Nejad P, Weber AN, J Biol Chem 2010 285 47 36486 36494 10.1074/jbc.M110.117200 20843814
12. Structural features of protein-nucleic acid recognition sites. Nadassy K, Wodak SJ, Janin J, Biochemistry 1999 38 1999 2017 10.1021/bi982362d 10026283 (Pubitemid 29094149)
13. Origins of specificity in protein-DNA recognition. Rohs R, Jin X, West SM, Joshi R, Honig B, Mann RS, Annu Rev Biochem 2010 79 1 233 269 10.1146/annurev-biochem-060408-091030 20334529
14. Protein-nucleic acid interaction: major groove recognition determinants. Xiong Y, Sundaralingam M, Encyclopedia of Life Sciences London: Macmlllan Reference Ltd 2001
15. Interaction between DNA and cationic surfactants: effect of DNA conformation and surfactant headgroup. Dias RS, Magno LM, Valente AJ, Das D, Das PK, Maiti S, Miguel MG, Lindman B, J Phys Chem B 2008 112 46 14446 14452 10.1021/jp8027935 18774843
16. New Water-Soluble Cationic Poly(p-phenylenevinylene) Derivative: the Interaction with DNA and Selective Fluorescence Enhancement Induced by ssDNA. Zhang W, Xu L, Qin J, Yang C, Macromol Rapid Commun 2013 34 5 442 446 12 10.1002/marc.201200696 23322714
17. Leucine-rich repeat 11 of TLR9 can tightly bind to CpG ODN and the positively charged residues are critical for the high affinity. Pan X, Yue J, Ding G, Li B, Liu X, Zheng X, Mengchen Y, Li J, Jiang W, Chong W, Zheng J, Zhou H, J Biol Chem 2012 287 36 30596 30609 10.1074/jbc.M112.396432 22822061
18. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. Ohto U, Yamakawa N, Akashi-Takamura S, Miyake K, Shimizu T, J Biol Chem 2012 287 48 40611 40617 10.1074/jbc.M112.404608 23055527
19. Human but not murine Toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. Grabiec A, Meng G, Fichte S, Bessler W, Kirschning CJ, J Biol Chem 2004 279 48004 48012 10.1074/jbc. M405311200 15342637 (Pubitemid 39540953)
20. Lipid Alike molecules that antagonize the effects of endotoxins on human monocytes. Golenbock DT, Hampton RY, Qureshi N, Takayama K, Raetz CR, J Biol Chem 1991 266 19490 19498 1918061 (Pubitemid 21908258)
21. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT, J Clin Invest 2000 105 497 504 10.1172/JCI8541 10683379 (Pubitemid 30127250)
22. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells. Tanamoto K, Azumi S, J Immunol 2000 164 3149 3156 10706705 (Pubitemid 30148976)
23. LPS, TLR4 and infectious disease diversity. Miller SI, Ernst RK, Bader MW, Nat Rev Microbiol 2005 3 36 46 10.1038/nrmicro1068 15608698 (Pubitemid 40028467)
24. Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9. Liua J, Xua C, Liu Y-L, Matsuo H, Hsieh RP-F, Lo J-F, Tseng P-H, Yuan C-J, Luo Y, Xiang R, Chuang T-H, Comp Immunol Microbiol Infect Dis 2012 35 443 451 10.1016/j.cimid.2012.03.008 22560893
25. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression. Griebel PJ, Brownlie R, Manuja A, Nichani A, Mookherjee N, Popowych Y, Mutwiri G, Hecker R, Babiuk LA, Vet Immunol Immunopathol 2005 108 11 16 10.1016/j.vetimm.2005.07.012 16098606 (Pubitemid 41317060)
26. The Universal Protein Resource (UniProt). The UniProt Consortium, Nucleic Acids Res 2007 35 193 D197 17142230
27. A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains. Wei T, Gong J, Rössle SC, Jamitzky F, Heckl WM, Stark RW, J Mol Model 2011 17 1 27 36 10.1007/s00894-010- 0697-5 20352268
28. Modeling of Human Prokineticin Receptors: Interactions with Novel Small-Molecule Binders and Potential Off-Target Drugs. Levit A, Yarnitzky T, Wiener A, Meidan R, Niv MY, PLoS One 2011 6 11 27990 10.1371/journal.pone. 0027990 22132188
29. I-TASSER: a unified platform for automated protein structure and function prediction. Roy A, Kucukural A, Zhang Y, Nat Protoc 2010 5 725 738 10.1038/nprot.2010.5 20360767
30. I-TASSER server for protein 3D structure prediction. Yang Z, BMC Bioinformatics 2008 9 40 10.1186/1471-2105-9-40 18215316 (Pubitemid 351267364)
31. VERIFY3D: Assessment of protein models with three-dimensional profiles. Eisenberg D, Luthy R, Bowie JU, Method Enzymol 1997 277 396 404
32. Cutting Edge: Species-Specific TLR9-Mediated Recognition of CpG and Non-CpG Phosphorothioate-Modified Oligonucleotides. Roberts TL, Sweet MJ, Hume DA, J Immunol 2005 174 605 608 15634876 (Pubitemid 40094250)
33. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Rutz M, Metzger J, Gellert T, Eur J Immunol 2004 34 2541 2550 10.1002/eji.200425218 15307186 (Pubitemid 39302811)
34. Ultra-Fast FFT protein docking on graphics processors. Ritchie DW, Venkatraman V, Bioinformatics 2010 26 2398 2405 10.1093/bioinformatics/btq444 20685958
35. Alard P, Calculs de surface et d'énergie dans le domaine de macromolécules (Ph.D. Thesis) Brussels, Belgium: Free University of Brussels 1992 120
36. The interpretation of protein structures: Estimation of static accessibility. Lee B, Richards FM, J Mol Biol 1971 55 379 400 10.1016/0022-2836(71)90324-X 5551392
37. Structural invariants in protein folding. Chothia C, Nature 1975 254 304 308 10.1038/254304a0 1118010
38. Interaction identification of Zif268 and TATAZF proteins with GC-/AT-rich DNA sequence: a theoretical study. Yang B, Zhu Y, Wang Y, Chen G, J Comput Chem 2011 32 3 416 428 10.1002/jcc.21630 20658568
39. DeLano WL, The PyMOL Molecular Graphics System San Carlos, CA: DeLano Scientific 2002